Publications
Specialty
Search
Journal of Clinical Pathways
06/03/2024
This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
06/03/2024
The Beacon Tip Sizing Catheter is used in angiographic procedures, diagnostic procedures and vascular interventions to make sure medical devices are sized correctly. These catheters are uniquely designed to help physicians correctly size devices, such as grafts, stents and balloons, to identify the best size of product to use for an individual patient’s situation.
EP Lab Digest
06/03/2024
In this video, Bradley Knight, MD, Editor-in-Chief of EP Lab Digest, discusses highlights from Heart Rhythm 2024.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
06/03/2024
“Edwards’ underlying rationale for separating Critical Care remains the same: we are laser focused on pursuing a strategy centered on structural heart disease,” said Bernard Zovighian, Edwards’ CEO.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
06/03/2024
UltraSight's AI-driven software offers real-time guidance, making cardiac ultrasound accessible and efficient, which may lead to quicker diagnoses and improved patient care. The company was awarded a patent for its real-time guidance solution for ultrasound devices.
Journal of Clinical Pathways
06/03/2024
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including perspectives from stakeholders on the disjointed health care system in the US and how clinical pathways can help fix it.
Psych Congress Network
06/03/2024
Join Nurse Kempf for this essential discussion on geriatric mental health care, and learn practical tips and strategies for providing compassionate and effective treatment to this vulnerable population.
Oncology
06/03/2024
David Andorsky, MD, discussed results from the phase 2 EPCORE NHL-6 trial, which showed that patients with R/R DLBCL and FL who were treated with subcutaneous epcoritamab demonstrated positive results in the outpatient setting.
Advances in Inflammatory Bowel Disease Network
06/03/2024
Dr Regueiro reviews the results of the SEQUENCE study that compared the efficacy of risankizumab and ustekinumab in the treatment of Crohn's disease, which he presented at Digestive Disease Week.
Advances in Inflammatory Bowel Disease Network, Gastroenterology
06/03/2024
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Oncology
06/02/2024
Jane Meisel, MD, discusses the impact novel antibody drug conjugates have had in the treatment of patients with metastatic breast cancer.
Oncology
06/02/2024
According to updated survival data from the phase 2 Young-PEARL study, palbociclib plus exemestane with ovarian function suppression prolonged progression-free survival but not overall survival among patients with HR-positive, HER2-negative metastatic breast cancer.
Oncology
06/02/2024
According to updated data presented at the 2024 ASCO Annual Meeting, lorlatinib has provided the longest progression-free survival ever reported among patients with advanced ALK-positive non-small cell lung cancer.
Oncology
06/02/2024
The phase 2 KEYVIBE-005 study found vibostolimab coformulated with pembrolizumab had durable antitumor activity and manageable safety among patients with advanced mismatch repair deficient (dMMR) endometrial cancer.
Oncology
06/02/2024
Suresh Ramalingam, MD, discussed results from the phase 3 LAURA study which demonstrated that administration of osimertinib following definitive chemoradiation improved PFS among patients with unresectable, stage 3, EGFR-mutated NSCLC.
Oncology
06/02/2024
Among patients with myelofibrosis who have both thrombocytopenia and anemia, study findings show full-dose pacritinib demonstrates efficacy for spleen, symptom, and transfusion response.
Oncology
06/02/2024
Oncology
06/01/2024
Corey Langer, MD, discusses treatment options for a patient with early-stage non-small cell lung cancer with a PD-L1 of 80%.
Oncology
06/01/2024
Areej El-Jawahri MD, discusses trial results that showed palliative care significantly improved the rates of discussion and documentation of end-of-life care preferences, reduced hospitalization, and improved quality of life for patients with AML and MDS.
Oncology
06/01/2024
Daniel Petrylak, MD, discussed results from a phase 1/2 study that demonstrated that ARV-766 was well tolerated and showed promising clinical activity among patients with androgen receptor LBD-mutated metastatic castration-resistant prostate cancer.